Kazumasa Komura

Osaka University of Pharmaceutical Sciences

Papers

4

Total Citations

16

H-Index

3

About

Dr. Kazumasa Komura is a pioneering surgeon-scientist advancing the frontiers of minimally invasive and robotic gynecologic oncology. His research centers on optimizing surgical techniques for early-stage cervical and endometrial cancers, with a particular focus on radical hysterectomy and sentinel lymph node biopsy. Dr. Komura’s landmark 2022 study, with 8 citations, critically compared minimally invasive surgery (MIS) to abdominal radical hysterectomy for early-stage cervical cancer, revealing that MIS was associated with higher recurrence and death rates—a finding that has reshaped clinical guidelines and sparked global debate. He further refined oncologic safety by evaluating outcomes after sentinel lymph node biopsy in cervical cancer, demonstrating its potential to reduce morbidity without compromising survival. In colorectal surgery, Dr. Komura introduced a novel robotic purse-string suture technique for intracorporeal anastomosis, improving recovery times and wound outcomes. He also pioneered a robot-assisted modified radical hysterectomy that uses indocyanine green to visualize and remove lymphatic vessels, enhancing surgical precision. With over 16 citations across his key works, Dr. Komura’s contributions are driving safer, more effective surgical standards in cancer care.

Research Focus

Key Achievements

3
H-Index
4
Papers
16
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of Prognosis between Minimally Invasive and Abdominal Radical Hysterectomy for Patients with Early-Stage Cervical Cancer
8 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 29
🏛 Institutions: Osaka University of Pharmaceutical Sciences

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 16 days ago